TBIO telesisbio.com: Operatsion rentabellik

Telesis Bio Inc. (TBIO) - korporativ logo

Telesis Bio, Inc. (TBIO) tezkor gen sintezi uchun BioXp tizimini taklif qilish orqali sintetik biologiya sohasida katta yutuqlarga erishmoqda. Operatsion foyda marjasi ushbu salohiyatni tasdiqlaydi va ushbu ko'rsatkich -200.80 ga tengdir. O'sish farmatsevtika sektoridagi tadqiqot va ishlanmalar (R&D) jarayonlarining avtomatlashtirilishiga bog'liq, garchi risklar professional muhitda robotlashtirilgan yechimlarning aniqligiga bo'lgan B2B ishonchini kengaytirish zarurati bilan bog'liq bo'lsa-da.

TBIO: Telesis Bio Inc. Sotuvning operatsion marjasi 28.04.2023 - 05.10.2024

Telesis Bio, Inc. (TBIO) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning jamlanma tahlili:Telesis Bio, Inc, TBIO
Telesis Bio, Inc brendining mahsuloti

Telesis Bio, Inc. (TBIO) kompaniyasining barqarorligi, keng ko'lamli tadqiqot va ishlanmalar (R&D) xarajatlari fonida DNK va mRNK sintezini avtomatlashtirish sohasidagi yetakchiligini monetizatsiya qilish qobiliyati bilan belgilanadi. Operatsion foyda farqini tahlil qilish orqali investor barcha ishlab chiqarish xarajatlari to'langan, ammo moliyaviy majburiyatlar va soliqlar hisobga olinmagan daromad qismini aniqlashi mumkin, bu esa biznes modelining ichki samaradorligini ob'ektiv baholash va kompaniyaning adolatli bozor chegirmasini belgilash imkonini beradi.

Raqobatchilar tahlili

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Maze Therapeutics, Inc. - Operatsion marja|Operatsion faoliyat rentabelligi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operatsion rentabellik|TSHA: Operatsion foyda koeffitsiyenti|Operatsion rentabellik uniQure Pharma|MGTX - Operatsion foyda bo'yicha marjinallik|Operatsion marja RGNX|Operatsion rentabellik SLDB (Solid Biosciences)|Ocugen Corp - Sotuvning operatsion marjasi|PACB: Operatsion foyda bo'yicha sotuv rentabelligi|benitec.com - Operatsion marja|DSGN - Operatsion marja|RCKT: Operatsion marja|FDMT (4D Molecular Therapeutics Inc) - Operatsion rentabellik|Sotuvning operatsion marjasi LXEO|Operatsion rentabellik KRRO|Operatsion marja EDIT|SLN - Sotuvning operatsion rentabelligi|Operatsion marja PRQR (ProQR)|CDXS - Sotuvning operatsion marjasi|Sangamo Therapeutics Inc. - Operatsion marja|NAUT - Operatsion marja|MGX: Operatsion marja|Sotuvning operatsion marjasi Precision BioSciences, Inc.|GBIO (Generation Bio) - Operatsion marja|Boundless Bio Inc. (BOLD) - Operatsion faoliyat rentabelligi|Sotuvning operatsion marjasi XCUR (exicuretx.com)|Imunon Inc - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja PHIO (Phio Pharmaceuticals Corp)|Operatsion foyda normasi MBIO|RNAZ - Operatsion rentabellik|Operatsion foyda normasi BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Operatsion rentabellik|Bluebird Bio - Operatsion foyda normasi|IPA (ImmunoPrecise Antibodies Ltd) - Operatsion marja|Sotuvning operatsion rentabelligi Omega Therapeutics, Inc. OMGA|Operatsion marja OMIC|RGLS (Regulus Therapeutics Inc.) - Operatsion foyda normasi|Operatsion marja SYRS (Syros Pharmaceuticals Inc.)|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik